Literature DB >> 36129879

Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti.

Mentor Ali Ber Lucien1, Katilla Pierre2, Gladzdin Jean-Denis3, Jonas Rigodon4, Caitlin M Worrell5, Alexia Couture6, Aspen Flynn6, Mauricio Cerpa Calderon3, Luis Felipe Codina3, Andrea S Vicari7, Samson Marseille2, Koama T Jean Baptiste4, Bernadette Fouche8, Gerard Joseph1, Ito Journel1, Kenold Rendel2, Yoran Grant-Greene4, Nadia P Jean-Charles4, Donald Lafontant2, Senou Amouzou2, Wilnique Pierre2, Marie Greta Roy Clement9, Stanley Juin4, Jacques Boncy1, Patrick Dely2.   

Abstract

BACKGROUND: Haiti's first COVID-19 cases were confirmed on March 18, 2020, and subsequently spread throughout the country. The objective of this study was to describe clinical manifestations of COVID-19 in Haitian outpatients and to identify risk factors for severity of clinical manifestations.
METHODS: We conducted a retrospective study of COVID-19 outpatients diagnosed from March 18-August 4, 2020, using demographic, epidemiological, and clinical data reported to the Ministry of Health (MoH). We used univariate and multivariate analysis, including multivariable logistic regression, to explore the risk factors and specific symptoms related to persons with symptomatic COVID-19 and the severity of symptomatic COVID-19 disease.
RESULTS: Of 5,389 cases reported to MOH during the study period, 1,754 (32.5%) were asymptomatic. Amongst symptomatic persons 2,747 (75.6%) had mild COVID-19 and 888 (24.4%) had moderate-to-severe disease; the most common symptoms were fever (69.6%), cough (51.9%), and myalgia (45.8%). The odds of having moderate-to-severe disease were highest among persons with hypertension (aOR = 1.72, 95% Confidence Interval [CI] (1.34, 2.20), chronic pulmonary disease (aOR = 3.93, 95% CI (1.93, 8.17)) and tuberculosis (aOR = 3.44, 95% CI (1.35, 9.14)) compared to persons without those conditions. The odds of having moderate-to-severe disease increased with age but was also seen among children aged 0-4 years (OR: 1.73, 95% CI (0.93, 3.08)), when using 30-39 years old as the reference group. All of the older age groups, 50-64 years, 65-74 years, 75-84 years, and 85+ years, had significantly higher odds of having moderate-to-severe COVID-19 compared with ages 30-39 years. Diabetes was associated with elevated odds of moderate-to-severe disease in bivariate analysis (OR = 2.17, 95% CI (1.58,2.98) but, this association did not hold in multivariable analyses (aOR = 1.22,95%CI (0.86,1.72)).
CONCLUSION: These findings from a resource-constrained country highlight the importance of surveillance systems to track emerging infections and their risk factors. In addition to co-morbidities described elsewhere, tuberculosis was a risk factor for moderate-to-severe COVID-19 disease.

Entities:  

Mesh:

Year:  2022        PMID: 36129879      PMCID: PMC9491605          DOI: 10.1371/journal.pone.0274760

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  27 in total

1.  Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020.

Authors:  Rebecca L Laws; Rebecca J Chancey; Elizabeth M Rabold; Victoria T Chu; Nathaniel M Lewis; Mark Fajans; Hannah E Reses; Lindsey M Duca; Patrick Dawson; Erin E Conners; Radhika Gharpure; Sherry Yin; Sean Buono; Mary Pomeroy; Anna R Yousaf; Daniel Owusu; Ashutosh Wadhwa; Eric Pevzner; Katherine A Battey; Henry Njuguna; Victoria L Fields; Phillip Salvatore; Michelle O'Hegarty; Jeni Vuong; Christopher J Gregory; Michelle Banks; Jared Rispens; Elizabeth Dietrich; Perrine Marcenac; Almea Matanock; Ian Pray; Ryan Westergaard; Trivikram Dasu; Sanjib Bhattacharyya; Ann Christiansen; Lindsey Page; Angela Dunn; Robyn Atkinson-Dunn; Kim Christensen; Tair Kiphibane; Sarah Willardson; Garrett Fox; Dongni Ye; Scott A Nabity; Alison Binder; Brandi D Freeman; Sandra Lester; Lisa Mills; Natalie Thornburg; Aron J Hall; Alicia M Fry; Jacqueline E Tate; Cuc H Tran; Hannah L Kirking
Journal:  Pediatrics       Date:  2020-10-08       Impact factor: 7.124

2.  Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.

Authors:  Soumya Sarkar; Puneet Khanna; Akhil Kant Singh
Journal:  J Med Virol       Date:  2020-12-29       Impact factor: 2.327

3.  When science goes viral: The research response during three months of the COVID-19 outbreak.

Authors:  Joanna Nowakowska; Joanna Sobocińska; Mateusz Lewicki; Żaneta Lemańska; Piotr Rzymski
Journal:  Biomed Pharmacother       Date:  2020-06-23       Impact factor: 6.529

4.  Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China.

Authors:  Yubo Wang; Yong He; Jin Tong; Yalan Qin; Ting Xie; Jianghua Li; Jianrong Li; Jianhua Xiang; Yong Cui; Elizabeth S Higgs; Jianglin Xiang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

7.  Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter?

Authors:  Prateek Lohia; Shweta Kapur; Sindhuri Benjaram; Abhilasha Pandey; Tanveer Mir; Berhane Seyoum
Journal:  J Diabetes       Date:  2021-01-16       Impact factor: 4.006

8.  Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis.

Authors:  Meghan O'Hearn; Junxiu Liu; Frederick Cudhea; Renata Micha; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2021-02-25       Impact factor: 5.501

9.  Diagnosis of COVID-19 in children: the story evolves.

Authors:  R Harwood; I Sinha
Journal:  BMC Med       Date:  2020-05-28       Impact factor: 8.775

10.  COVID-19 Case Investigation and Contact Tracing Efforts from Health Departments - United States, June 25-July 24, 2020.

Authors:  Kimberly D Spencer; Christina L Chung; Alison Stargel; Alvin Shultz; Phoebe G Thorpe; Marion W Carter; Melanie M Taylor; Mary McFarlane; Dale Rose; Margaret A Honein; Henry Walke
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-22       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.